| Prof Chuen Yan Cheng | |
| Birth Date: | June 18, 1954 |
| Birth Place: | Hong Kong, China |
| Nationality: | American |
| Field: | Biochemistry |
| Work Institution: | Rockefeller University |
| Alma Mater: | Chinese University of Hong Kong (B.Sc.) University of Newcastle, Australia (Ph.D.) |
| Known For: | Male contraceptive drug |
| Prizes: | Richard E. Weizman Memorial Award Best Scientific Paper Award |
Chuen Yan Cheng is a Senior Scientist for the Population Council's Center for Biomedical Research. He is most well known as the inventor of the non-steroid male contraceptive drug——Adjudin,[1] [2] [3] [4] which is the first male contraceptive drug on the market now finished clinical trials showing no side effects.[5] [6]
He graduated from the Chinese University of Hong Kong with a B.Sc. in 1977, and obtained his Ph.D. in biochemistry and cell biology at the University of Newcastle, Australia, in 1981. He came to New York as a Population Council post-doctoral trainee in 1981, studying in the laboratory of Drs. Wayne Bardin, Neal Musto, and Glen Gunsalus and was appointed as a research investigator in December 1982.
Cheng's research focuses on the development of a novel contraceptive for human males. These studies currently are supported by grants from the National Institutes of Health, the CONRAD Program, and the Andrew Mellon Foundation.